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Abstract. Collagen VII, the major component of cuta-
neous anchoring fibrils is expressed at a low level by
normal human keratinocytes and fibroblasts in vitro.
In cocultures of these two cell types, signals from fibro-
blasts enhance expression of collagen VII by keratino-
cytes and vice versa. In this study, the effects of a pos-
sible mediator of such a stimulation, transforming
growth factor-ß (TGF-ß), were investigated. Its effect
on the expression and deposition of the highly insolu-
ble collagen VII was assessed in a semiquantitative
manner by a newly developed enzyme-linked immuno-
assay which is based on immunoblotting . In keratino-
cyte monocultures, 0.5-20 ng/ml of TGF-ß2 induced a
dose-dependent stimulation of collagen VII expression
as measured per microgram of DNA . The maximal
enhancement was about sevenfold compared to con-
HE dermo-epidermal junction of the skin represents
an epithelial-mesenchymal interface with a unique
structure and highly specialized functions (Palade and
Farquhar, 1965 ; Bruns, 1969 ; Briggaman and Wheeler,
1975x; Tidman and Eady, 1984 ; Burgeson, 1987). One ofits
main functions is to provide the resistance ofthe skin against
shearing forces which requires strong cohesion of the skin
layers. This is achieved by several interconnected macromo-
lecular networks which attach the epidermis to the basement
membrane and to the underlying dermal connective tis-
sue (Timpl, 1989; Burgeson et al ., 1990 ; Yurchenko and
Schittny, 1990). One of the major structures mediating the
attachment is the anchoring fibril network that extends from
the basement membrane to the anchoring plaques in thepapil-
lary dermis (Sakai et al., 1986; Keene et al., 1987) . Abnor-
malities ofthe anchoring fibrils lead to separation of the epi-
dermis from the dermis and to clinical blistering of the skin,
as seen in dystrophic epidermolysis bullosa, a group of
inherited blistering disorders (Briggaman and Wheeler,
1975b; Hashimoto et al ., 1976; Tidman and Eady, 1985 ;
Heagerty et al., 1986 ; Bruckner-Tuderman et al., 1989,
1. A preliminary report of this paper was presented at the XXIth Annual
Meeting of the European Society for Dermatological Research, June 1-4,
1991, Copenhagen, Denmark.
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trols. The effect of TGF-ß2 was observed already after
12 h, with a steady increase at least up to 3 d. As pre-
vious studies have implicated, untreated cocultures of
keratinocytes and fibroblasts exhibited a higher basic
level of collagen VII expression, which could be fur-
ther stimulated about twofold by TGF-ß2. Fibroblasts
alone synthesized very minor quantities of collagen
VII and could be only weakly stimulated by TGF-ß2.
This growth factor seems a specific enhancer of colla-
gen VII since the expression of laminin, collagen IV,
as well as total protein was increased to a much lesser
extent. Our data suggest that TGF-ß may be an impor-
tant mediator of epithelial-mesenchymal interactions
and may regulate the synthesis of the anchoring fibrils
at the skin basement membrane zone.
1991x), or in epidermolysis bullosa acquisita, an inflamma-
tory autoimmune bullous disease (Woodley et al ., 1988) .
Collagen VII is the major structural component of the an-
choring fibrils (Sakai et al ., 1986; Burgeson et al ., 1990) .
The structure, biosynthesis and supramolecular assembly of
this collagen are known only in part (Lunstrum et al., 1986;
Bruckner-Tuderman et al ., 1987; Bächinger et al., 1990;
Parente et al., 1991), and the regulation of these events re-
mains to be elucidated. Epidermal cells appear the main site
of collagen VII production, but their biosynthetic activity is
under dermal control (Regauer et al ., 1990; K6nig and
Bruckner-Tuderman, 1991) . In cocultures of keratinocytes
and fibroblasts, expression of collagen VII is enhanced as
compared to monocultures of either cell type, and in three-
dimensional skin equivalent cultures collagen VII can be de-
tected in the epidermal, but not dermal cells (Kbnig and
Bruckner-Tuderman, 1991).
The nature of the mesenchymal-epithelial signals mediat-
ing the stimulation of collagen VII expression in cocultures
remains unknown. Direct cell-cell contacts seem less likely
because epithelial cells express collagen VII in skin equiva-
lents in which no physical contact between fibroblasts and
keratinocytes exists . In contrast, growth factors seem likely
candidates as mediators of at least some signals, since their
effects on cellular behaviour and production of the extracel-
lular matrix, and their interactions with the matrix have be-
679come known in many in vitro systems (for review, see Nathan
and Sporn, 1991). A cytokine with a broad spectrum of
effects on extracellular matrix is the transforming growth
factor-0 (TGF-ß)' peptide family (for reviews, see Roberts
et al., 1988, 1990; Massagué, 1990). In addition to control-
ling cell growth, differentiation, and function, it has been
shown to play an important role in remodelling of tissues by
affecting the expression of, e.g., many collagens, fibronec-
tin, elastin, matrix metalloproteinases, or their inhibitors
(Roberts et al ., 1988, 1990; Massagué, 1990).
In this study we show that TGF-ß2 stimulates in a dose-
dependent manner the expression of collagen VII, a major
component of the dermo-epidermal junction and a structural
protein of the anchoring fibrils. The effect on the expression
ofcollagen VII is significantly larger than on other basement
membrane zone proteins such as laminin or collagen IV.
Materials and Methods
TGF-0
Recombinant human TGF-ß2 was a kind gift from Drs. K. Miiller and N.
Cerletti (Ciba-Geigy AG, Basel, Switzerland) . It was solubilized in 10 mM
HCI and 10% ethanol at a concentration of0.1 mg/ml . This stock solution
was diluted with PBS containing 0.05% BSA to a final TGF-ß2 concentra-
tion of 200 ng/ml .
Cell Cultures
Human skin fibroblasts were initiated from primary explants and grown in
DMEM supplemented with 10% FCS, 4 MM t.-glutamine, 100 U/ml peni-
cillin, 100 gg/ml streptomycin, and 0.25 wg/ml amphotericin B (Gibco
Laboratories, Grand Island, NY). Human keratinocytes were released from
skin by trypsinization and cultured in serum-free keratinocyte growth
medium (KGM) containing 0.09 mM calcium (Boyce and Ham, 1983), 50
hg/ml bovine pituitary extract (BPE) and 5 ng/ml recombinant human EGF
(Gibco Laboratories). Cells from the first or second passage were used in
the experiments. For cocultures, fibroblasts were seeded at a density of
8,000 cells/cm' in DMEM with 10% FCS. 24 h later, the medium was
replaced with KGM, and keratinocytes were added at a density of
40,000-80,000 cells/cm'. Cylindroma cells were initiated and cultured in
KGM as previously described (Bruckner-Tuderman et al., 1991b). Before
assessing collagen VII expression, serum or BPE were omitted from the
media for at least 48 h. For the same time period, 50 wg/ml ascorbate was
added to the cultures.
TreatmentofCellCultures with TGF-02
Keratinocytes, fibroblasts, cocultures, or cylindroma cells were cultivated
to semi-confluency in complete culture medium. TGF-ß2 treatment was
carried out in serum- and BPE-free medium supplemented with 50 hg/ml
ascorbate. Appropriate amounts of TGF-ß2 stock solution (see above) were
added to the medium once, and the medium was not renewed during the
incubation period. The incubation period was 48 h for IF experiments and
72 h for the measurements with the enzyme-linked immunoassay. To control
cultures, corresponding amounts of PBS containing 0.05% BSA (TOF-ß2
solvent) were added for the incubation period.
Antibodies
For detection of collagen VII, polyclonal affinity-purified antibodies to the
triplehelical domain of human collagenVII were used (Bruckner-Tuderman
et al., 1987) . The mAb to human collagen IV was kindly provided by Dr.
B. Odermatt, Department of Pathology, University of Zurich (Odermatt et
al., 1984), and the polyclonal antibodies to human laminin were a generous
gift from Dr. M. Paulsson, M. E. Müller Institute for Biomechanics,
1. Abbreviations used in thispaper: BPE, bovine pituitary extract; IF, indi-
rect immunofluorescence staining; KGM, keratinocyte growth medium,
substituted with BPE and EGF; TGF-ß, transforming growth factor-ß.
The Journal of Cell Biology, Volume 117, 1992
University ofBerne (Paulsson et al., 1987). FITC-labeled antirabbit and an-
timouse antibodies were purchased from Dakopatts (Glostrup, Denmark).
Peroxidase-labeled goat antirabbit antibodies were obtained from Kir-
kegaard & Perry (Gaithersburg, MD).
Indirect Immunofluorescence Staining (IF)
Cells cultured on cover slips or on plastic LabTekR chamber slides (Nunc
Inc., Naperville, IL) were washed twice with TBS, and permeabilized and
fixed with 100% methanol for 15 min at -20°C. Incubation with the first
antibody was performed overnight and with the FITC-conjugated second an-
tibody for l h.
ProteinandDNA Determination
The total cell culture proteins were precipitated with 10% TCA and dis-
solved in 1 M NaOH. The protein concentration was measured by a
modified Lowry-assay (Lowry et al., 1951; Hudson and Hay, 1989) using
BSA for calibration. The DNA content ofthe cultures was measured accord-
ing to Labarca and Paigen (1980) .
Enzyme-linkedImmunoassayforCollagen VII
Due to an extensive insolubility ofthe tissue formof collagen VII in physio-
logical solutions, common quantitative immunoassays such as ELISA or
RIA were not reproducible. A new solid phase immunoassay based on quan-
titative extraction of collagen VII with denaturing and reducing agents, im-
munoblotting and measurement ofthe antibody-bound enzyme activity with
a water soluble chromophore substrate was developed.
Cells were cultured in 25-cm2 flasks to early confluency and treated
with TGF-ß2 according to the experimental protocol . After the incubation
period, the medium was harvested and proteinase inhibitors including I
mM phenylmethane-sulfonyl fluoride, 10 mM EDTA, 20 mM N-ethylmale-
imide, and 100 mM e-aminocaproic acid were added. Before further pro-
cessing, the medium was stored on ice. The cell layer was washed twice
with ice-cold TBS, and homogenized in cold distilled water by sonication.
After aliquots had been separated for DNA assays, the cells were combined
with the medium and precipitated with 75% ethanol on ice for 1 h . After
centrifugation with 17,000 g for 20 min, the pellet was dissolved in 500 Al
of a buffer containing 8 M urea, 2% SDS, 0.1 M 1,4-dithioerythritol and
0.1 M Tris-HCI (pH 6.8). After heating at 100°C for 5 min, the extract was
extensively dialyzed against SDS-PAGE sample buffer containing 0.8 M
urea, 0.1 M Tris, pH 6.8, 2 % SDS, 0.002% bromphenol blue, and 5 %
glycerine. The volume of all samples was adjusted to the largest volume by
adding sample buffer, usually to 750 pl. 50 or 100 Al of each extract was
separated by SDS-PAGE (Lämmli, 1970) under reducing conditions, with
a 4.5-15% polyacrylamide gradient gel. This was followed by electrotrans-
fer of the proteins onto nitrocellulose (Towbin et al ., 1979). To ensure a
complete transfer, 0.1% SDS was added to the transfer buffer. The lanes on
the filter were marked after staining with 0.2% Ponceau S Red (Sigma
Chemical Co., St. Louis, MO) in TBS. After blocking with 2% defatted
milk powder in TBS for 30 min, the nitrocellulose sheet was reacted over-
night with affinity-purified rabbit antihuman collagen VII antibodies
(Bruckner-Tuderman etal ., 1987). Washing with TBS was followed by incu-
bation with peroxidase-labeled goat anti-rabbit IgG antibody for 2 h.
After the reaction with the antibodies, lanes with collagen VII standards
were cut out and reacted with the water-insoluble substrate 4-chloro-l-
naphtol . The migration position ofcollagen VII on the nonreacted nitrocel-
lulose was marked with help of these standards, and the corresponding
bands were excised and transferred to test tubes. They were incubated in
0.5 ml of a substrate solution containing 0.03% o-phenylenediamine, 25
mM citric acid, 50 mM Na2HPO4, and 0.01% hydrogen peroxide for 15
min. The reaction was stopped by adding 100 AI of 2 M sulfuric acid. The
nitrocellulose stripes were transferred into new tubes, and residual bound
substrate was eluted with200 Al ofN,N-dimethyl formamide. Both chromo-
phore solutions were combined, clarified by short centrifugation in a
microfuge, and the absorbance was read at 492 nm.
For calibration, 5-30 Al ofcollagen VII containing skin extract were run
on the same gel and measured in the same assay, parallel with the test sam-
ples. Due to the semiquantitative nature of this solid-phase immunoassay,
arbitrary units for type VII collagen were defined. One unit corresponded
to the amount of collagen VII present in 1 Al of dermis extract that was pre-
pared by using 400 Al of extraction buffer per cm2 of skin surface, as de-
scribed (Stanley et al ., 1985; Bruckner-Thdermanet al., 1987) . Application
of 5-30 Al ofskin extract as a standard resulted in a linear response in the
assay. Fig. 1 (A) shows such a standard series stained with a water-insoluble
680peroxidase substrate, 4-chloro-l-naphtol, and B shows the corresponding
absorbances of the reaction with o-phenylenediamine as a water-soluble
substrate. All samples were measured in the linear range of the assay .
Results
For initial observation ofthe effects ofTGF-0 on collagen VII
expression in vitro, small cultures on coverslips were treated
with TGF-,ß2 and subjected to IF. Semiconfluent keratino-
cytes, fibroblasts, cocultures, or cylindroma cells were culti-
vated for 2 d in serum- or BPE-free medium which was sup-
plemented with 20 ng/ml TGF-/ß2 and 50 Ag/ml ascorbate
before processing for IF. In controls, the media were sup-
plemented with ascorbate and PBS containing 0.05% BSA
but no TGF-ß2 .
In dermal fibroblasts, the basal expression of collagen VII
was very low (Fig . 2 a), and incubation with TGF-ß 2 in-
duced only a discrete increase of immunoreaction (Fig . 2 b) .
In contrast, the expression of collagen VII by keratinocytes
could be significantly stimulated by TGF-ß2 (Fig . 2, c and
d) . In cocultures, the basal expression of collagen VII was
stronger than in either cell type alone (Fig . 2 e), but could
still be enhanced by TGF-ß2 to some extent (Fig . 2 f) . As
we have shown previously (Bruckner-Tuderman et al .,
1991b), epithelial cells derived from a benign skin tumor, the
cylindroma, expressed collagen VII at a relatively high level
(Fig . 2 g) . Also in these "high producers," an enhancement
by TGF-ß2 was observed (Fig . 2 h) . For preliminary assess-
ment of the degree of stimulation, the response of the cells
to different concentrations of TGF-ß2 was estimated by vi-
sual scoring of the IF staining (Table I) . Addition of 1-30
ng/ml of TGF-ß 2 resulted in a very weak stimulation in
fibroblasts, whereas a clear dose-dependent response was
observed in keratinocytes, cocultures, and cylindroma cells .
In control experiments, collagen VII was similarly expressed
in keratinocytes and cocultures when BPE was included in
the medium (data not shown) .
The subjective impression of increased collagen VII ex-
pression in TGF-ß2-treated cultures was confirmed with
immunoblotting of culture extracts . Small quantities ofcolla-
gen VII could be extracted from untreated 25-cm2 sub-
confluent keratinocyte cultures (Fig . 3, lane 2) . However,
significantly higher amounts were found in cultures in-
cubated with 5 ng/ml TGF-ß2 for 3 d (Fig . 3, lane 3) . In all
10
Figure 1. Enzyme-linked solid
phase immunoassay for colla-
gen VII. The tissue form of
collagen VII was detected in
5-30 jl of dermal extract by
conventional immunoblotting
(a) or by theassay usinga sol-
uble chromophore substrate
(b) . For calibration of the as-
say, the same amounts of der-
mal extract as in a were used
as standards . One arbitrary
unit of collagen VII corre-
sponds to the amount present
in 1 jul of dermal extract, pre
pared as described in Materi-
Colle aen V11 [units]
￿
als and Methods .
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Table I . Comparison ofCollagen VII Synthesis by
Cutaneous Cells in the Absence or Presence ofTGF-0
Indirect immunofluorescence staining of cells grown on cover slips was scored
visually . +/-, questionable staining ; +, moderate staining ; ++, prominent
staining ; +++/++++, strong staining .
extracts, the intact tissue form of collagen VII was present,
and no degradation products were observed .
For semiquantitative dose-response measurement, ker-
atinocytes and cocultures were incubated with 0.1-20 ng/ml
TGF-ß2 for 3 d . The culture extracts were subjected to the
solid-phase immunoassay, and the collagen VII content was
assessed per microgram of DNA . In control keratinocytes
(Fig . 4 A), the collagen VII level corresponded to Nl U/p,g
DNA (one arbitrary unit was defined as the amount of colla-
gen VII present in 1 Al of dermal basement membrane zone
extract, as described in Materials and Methods) . TGF-ß2
induced a dose-dependent stimulation which was about four-
fold with 0.5 ng/ml and about sevenfold with 20 ng/ml TGF-
02 . A similar dose-response was found in cocultures (Fig . 4
B) . As expected from the preliminary experiments with IF
staining, the basal expression of collagen VII in these cul-
tures was higher, N5 U/Ag DNA . It could be stimulated
-1 .5-fold with 0.5 ng/ml, and tit-fold with 20 ng/ml
TGF-N2 "
In time-course experiments, a slight effect of TGF-ß2 on
collagen VII expression was seen after 12 h incubation, and
a clear stimulus was measured after 24 h (Fig . 5), with a
steady increase up to 72 h .
TGF-ß2 was found to stimulate to a lesser extent the ex-
pression of two other basement membrane zone proteins,
laminin and collagen IV (Table II) . As assessed by IF and
visual scoring, the basal expression of laminin in keratino-
cytes was prominent but could still be stimulated by TGF-ß2
in a dose-dependent way. When stained with antibodies to
collagen IV, keratinocytes showed an immunofluorescence
signal that was indistinguishable from the negative controls .
Incubation with TGF-ß2 induced a barely visible staining
for collagen IV.
Total protein content of the keratinocyte cultures treated
with up to 5 ng/ml TGF-ß2 for 3 d increased by 20-25 %,
significantly less than the content of collagen VII . As ex-
pected from the well-known inhibitory effect of TGF-0 on
keratinocyte proliferation (Shipley et al ., 1986), the DNA
content in cultures treated with 0.5-20 ng/ml TGF-ß2 for
3 d was 25-30% lower than in control cultures .
Discussion
In the present study we demonstrate that TGF-ß 2 increases
in a dose-dependent manner the expression of collagen VII
681
TGF-0
nglml
Fibroblasts Keratinocytes Cocultures Cylindroma Cells
o +/- + ++ ++
5 +/- ++ +++ +++
10 +/- +++ ++++
20 + +++ +++ ++++
30 + +++by cutaneous cells. The quantitation of collagen VII in tis-
sues or in cell cultures has been difficult in the past, due to
a tendency to aggregation and subsequent insolubility of the
protein, a fact that has impaired studies on regulation of this
collagen . To circumvent this problem, a new enzyme-linked
immunoassay was utilized here. It is based on immunoblot-
ting and the use of a water-soluble chromophore substrate,
and allows semiquantitative assessment of collagen VII which
can be solubilized under denaturing and reducing condi-
tions . The assay is linear over a wide range of antigen
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Figure 2. Enhanced collagen
VII expression in TGF-ß-
treated cells . Immunofluores-
cence staining with antibodies
to collagen VII of fibroblasts
(a and b), keratinocytes (c and
d), cocultures (e and f), and
cylindroma cells (g and h) .
The cultures were incubated
with 20 ng/ml of TGF-ßZ and
ascorbate in serum- or BPE-
free medium for 3 d (b, d, f,
and h) as described in Materi-
als and Methods . Control cul-
tures (a, c, e, and g) were in-
cubated with ascorbate alone .
Bars, 10 gym .
concentration, and shows small interassay variation . This
method can be adapted for any other protein which cannot
be assessed with ELISA or RIA due to insolubility or ten-
dency to aggregation .
In vitro, collagen VII can be synthesized by both fibro-
blasts and epithelial cells (Stanley et al ., 1985 ; Lunstrum et
al ., 1986 ; Bruckner-Tuderman et al., 1987 ; Kbnig and
Bruckner-llxderman, 1991) . It is unclear, however, which
cells produce collagen VII and deposit anchoring fibrils in
situ, and how these processes are regulated . Recent studies
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Figure 3 . Immunoblotting of
collagen VII extracted from
TGF-0-treated keratinocyte
cultures . 25-cm2 cultures
were solubilized in 750 ttl of
extraction buffer and immuno-
blotted with 100 ttl per well .
(Lane 1) Standard, tissue form
ofcollagen VII extracted from
normal dermis ; (lane 2) colla-
gen VII extracted from control
keratinocytes ; and (lane 3)
from keratinocytes treated with
5 ng/ml of TGF-ß2 for 3 d as
described in Materials and
Methods ; (lane 4) standard,
triple helical fragment of col-
lagen VII . Molecular weights
deduced from collagenous
standards are indicated on the
right .
have suggested that keratinocytes represent the main site of
collagen VII production in vitro (Goldsmith et al ., 1991 ; K5-
nig and Bruckner-Tuderman, 1991) and in vivo (Smith and
Sybert, 1990 ; Regauer et al ., 1991) . However, fibroblasts
possess an inherent capacity to produce this protein, and
they can be stimulated to do so under certain conditions,
such as in cocultures with keratinocytes . This stimulation of
collagen VII expression in cocultures is mutual as the expres-
sion by keratinocytes was enhanced as well (König and
Bruckner-Tuderman, 1991) . The nature of the signals medi-
ating the stimulatory effects remains elusive, but it is likely
that autocrine and paracrine factors are important because
direct cell-cell contact is not required for enhanced collagen
VII expression in cocultures .
A cytokine with a central role in the development and
maintenance of the extracellular matrix in general, is the
TGF-,ß peptide family. It upregulates the expression of multi-
ple genes coding for extracellular matrix proteins, such as
fibronectin, laminin (Ignotz et al ., 1987, Wikner et al.,
Figure4. Response ofcollagen
VII expression to increasing
concentrations of TGF-ß . Du-
plicate cultures of subconflu-
ent keratinocytes (a) or cocul-
lures (b) were treated with
TGF-02 for 3 d, and collagen
VII content ofthe cultures was
assessed by the enzyme-linked
immunoassay as described in
Materials and Methods . Results
are expressed as arbitrary units
ofcollagen VII per microgram
of DNA and plotted against
the concentration of TGF-0 2
on a semilogarithmic scale .
Each dot represents the value
obtained from one cultureflask .
At both 0 and 10 ng/ml TGF-
02 in a, and at 0 nglml in b,
TGF-0 (ngimV
￿
two dots are superimposed .
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Figure 5 . Time course of the
effect of TGF-0 on collagen
VII expression by keratino-
cytes . Subconfluent cultures
were incubated with 5 ng/ml
TGF-F+2 for 12-72 h in the
presence ofascorbate (o) . The
growth factor wasomitted from
Time llli
￿
parallel control cultures (A)
A clearstimulation ofcollagen
VII expression was visible after 24 h, with a steady increase up
to 72 h . Collagen VII content of the cultures was assessed by the
enzyme-linked immunoassay as described in Materials and Meth-
ods . Results are expressed as arbitrary units of collagen VII per
microgram of DNA . Each dot represents the value obtained from
one culture flask . At 24 h, two dots are superimposed .
12
s
s
3
0
0 12 24 36 48 60 72 84
1988 ; Vollberg et al., 1991), and collagens I, III, V (Rossi
et al., 1988), II (Varga et al ., 1987), or IV (Vollberg et al.,
1991) . In the present study we demonstrated that TGF-N2
also stimulates the production of collagen VII by cutaneous
cells in a dose- and time-dependent manner. Time course ex-
periments showed an effect that was visible after 12 h, with
a steady increase up to 48-72 h . Therefore, the cells were
treated with TGF-ß2 for this period of time before assessing
changes in collagen VII production .
Keratinocytes and cocultures were very responsive to
0.1-20 ng/ml TGF-ß2, showing a two- to sevenfold increase
of collagen VII production, whereas fibroblasts in monocul-
ture were poor responders . The stimulation was stronger in
keratinocytes than in cocultures, most likely due to the al-
ready enhanced expression in untreated cocultures . The
effect of TGF-ß2 did not depend on the presence of EGF
in the culture medium, since control experiments in the
absence ofEGF exhibited similar results (data not shown) .
The effect of TGF-ß2 on collagen VII expression was clearly
greater than on the production of other basement membrane
components such as laminin and collagen IV . In addition,
TGF-ß2 increased the total protein synthesis only by 25-30%,
implicating that the increase in collagen VII production was
not a mere reflection of a generally induced protein synthesis .
Although TGF-ß, which is also expressed in normal skin
and keratinocytes in vitro (Gruschwitz et al ., 1990) was not
assessed in this study, a similar effect on collagen VII expres-
sion can be expected . In other cell systems, the two subtypes
exert similar effects mediated by shared receptors which bind
Table IL Effect ofTGF-0 on Expression ofCollagen IVand
Laminin by Keratinocytes In Vitro
Indirect immunolluorescence staining of cells grown on cover slips was scored
visually . -, no staining ; +/-, questionable staining ; ++, prominent stain-
ing ; +++/++++, strong staining .
683
TGF-0 Laminin Collagen IV
nglml
0 +++ -
5 ++++ +/-
10 ++++ +/-
20 ++++ +/_both subtypes (Massagué, 1990), and fibronectin production
is stimulated by both subtypes but stronger by TGF-ß,
(Hashiro et al ., 1991) .
The response of normal, low passage skin cells to TGF-
tß2 in the present study was comparable to observations
made in other cell culture systems where 0.5-12 .5 ng/ml of
TGF-ß stimulated -6-10-fold the expression of fibronectin,
laminin (Ignotz and Massagué, 1986, Vollberg et al ., 1991,
Hashiro et al ., 1991) and other collagens (Varga et al ., 1987,
Rossi et al ., 1988, Madri et al ., 1988, Vollberg et al., 1991) .
This suggests that TGF-0 in picomolar concentrations regu-
lates the expression of extracellular matrix components, in
particular collagen VII, by keratinocytes and fibroblasts
alongthe cutaneous basement membrane zone. Both human
fibroblasts and keratinocytes are capable of synthesizing and
secreting TGF-ß (Lawrence et al ., 1984; Partridge et al.,
1989) and they possess specific receptors for this factor
(Tucker et al., 1984). It thus seems likely that TGF-ß is
responsible for at leastpart ofthe stimulation of collagen VII
observed in cocultures of keratinocytes and fibroblasts.
However, the fact that fibroblasts in monoculture can be
stimulated with TGF-ß2 to express collagen VII to a lesser
extent than fibroblasts that are cocultured with keratinocytes,
points to the existence of additional keratinocyte-derived
mediators that regulate mesenchymal-epithelial interactions
in vitro. Potential candidate factors include FGF, PDGF, and
EGF which modulate connective tissue metabolism, e.g.,
during reparatory processes and wound healing (Nanney,
1990; Mustoe et al ., 1991). The role of such factors in the
regulation of mesenchymal-epithelial interactions in skin
and of biogenesis of the anchoring fibrils is being presently
investigated in our laboratory.
The precise mechanisms of TGF-ß action on expression of
collagen VII remain unknown. In other instances, stimula-
tion of collagen gene transcription via nuclear factor 1 bind-
ing (Rossi et al., 1988), or preferential stabilization of colla-
gen mRNA (Raghow et al ., 1987) have been reported. On
the other hand, TGF-ß represses matrix metalloproteinase
expression and activity (Woessner 1991), an effect which
could lead to accumulation of a protein in the matrix.
In many dermatologic disorders with blistering tendency,
abnormal structure and function of the anchoring fibrils can
be accompanied by secondary proteolysis. In genetic dis-
eases such as dystrophic epidermolysis bullosa, synthesis of
collagen VII is impaired, the dermo-epidermal coherence
inadequate, and destruction of the dermal connective tissue
often evident (Hashimoto et al., 1976 ; Bruckner-Tuderman
et al., 1989, 1990). Another example is found in healing
burn wounds, where blisters tend to form very easily in spite
of complete re-epithelialization of the wound. In such
wounds, the globular domains of the anchoring fibrils are
present but the collagenous domains are missing, probably
due to excessive collagenolytic activity in the dermal granu-
lation tissue (D. Woodley, E. Bauer, and L. Bruckner-
T1lderman, manuscript in preparation) . In pathologic situa-
tions like the above, TGF-ß may exhibit therapeutic potential
due to its multiple regulatory effects on the extracellular ma-
trix, i.e., stimulation of collagen VII but inhibition of col-
lagenase and stromelysin expression, as well as stimulation
of specific matrix metalloproteinase inhibitors (Werb, 1989;
Massagué, 1990; Woessner, 1991) . Profound understanding
of the effects of growth factors and cytokines on the biology
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of the skin basement membrane zone is essential for plan-
ning therapeutic regimens utilizing TGF-ß or other biologi-
cally active factors.
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